687 results on '"Willems, Stefan M."'
Search Results
202. Using Intratumor Heterogeneity of Immunohistochemistry Biomarkers to Classify Laryngeal and Hypopharyngeal Tumors Based on Histologic Features
203. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma
204. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas
205. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
206. Interobserver variation among pathologists for delineation of tumor on H&E-sections of laryngeal and hypopharyngeal carcinoma. How good is the gold standard?
207. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
208. Comparison of Next-Generation Sequencing and Mutation-Specific Platforms in Clinical Practice
209. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis
210. Assessment of algorithms for mitosis detection in breast cancer histopathology images
211. Detailed imaging and genetic analysis reveal a secondaryBRAFL505Hresistance mutation and extensive intrapatient heterogeneity in metastaticBRAFmutant melanoma patients treated with vemurafenib
212. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma
213. Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology
214. The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma
215. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
216. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?
217. Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer.
218. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
219. Use of the 2‐μm continuous wave thulium laser for the resection of oral squamous cell carcinomas does not impair pathological assessment
220. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
221. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2
222. Promoter hypermethylation using 24-gene array in early head and neck cancer
223. Resection of early oral squamous cell carcinoma with positive or close margins: Relevance of adjuvant treatment in relation to local recurrence
224. Molecular subtyping of colorectal cancer for identification of patients with a mesenchymal tumor type who might benefit from TGF-beta inhibition.
225. Tumor heterogeneity and personalized cancer medicine: are we being outnumbered?
226. The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
227. Molecular subtyping of colorectal cancer to identify a mesenchymal tumor type that might benefit from TGF-beta pathway inhibition.
228. Carboxyl-Ester Lipase Maturity-Onset Diabetes of the Young Is Associated With Development of Pancreatic Cysts and Upregulated MAPK Signaling in Secretin-Stimulated Duodenal Fluid
229. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma
230. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
231. Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice
232. Identification of recurrentFGFR3fusion genes in lung cancer through kinome‐centred RNA sequencing
233. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas.
234. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
235. Poor Correlation of Histologic Parameters Between Biopsy and Resection Specimen in Early Stage Oral Squamous Cell Carcinoma.
236. Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.
237. Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC.
238. Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
239. Peptide and protein imaging mass spectrometry in cancer research
240. Running GAGs: myxoid matrix in tumor pathology revisited
241. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
242. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
243. Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib.
244. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
245. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
246. Use of the 2-[mu]m continuous wave thulium laser for the resection of oral squamous cell carcinomas does not impair pathological assessment.
247. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
248. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma.
249. TGF-β An emerging player in drug resistance.
250. The Hidden Link of Exosomes to Head and Neck Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.